CSF2 and acute myeloid leukemia: To determine whether human AML-derived eosinophil-like cells could revert to an immature proliferative state we sorted the SSCHIGHCD11B+CD15– eosinophil population from 6 day ATRA/GM-CSF treated HT93 cultures, then withdrew ATRA/GM-CSF.